Skip to the page

Data / Form D filings / Nexsis Biosciences LLC

Nexsis Biosciences LLC: Form D filing

Nexsis Biosciences LLC, a biotechnology company in St. Augustine, FL, filed a Form D with the SEC in 2024. The latest, on June 24, 2024, reports $725,000 sold of a $725,000 offering to 13 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
186 Silver Sage Lane, St. Augustine, FL, 32095
Phone
(770) 241-0270
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Florida
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2028035

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 24, 2024New notice$725,000$725,00013Dec 21, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Beecher LewisExecutive Officer, Director
Scott CartExecutive Officer, Director
John C. PirrisDirector
John C. Thomas, Jr.Executive Officer

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Jun 24, 2024 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Nexsis Biosciences LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.